SPP1 and hepatocellular carcinoma: Although the molecular mechanism of SPP1-mediated crosstalk between SPP1+ macrophages and CAFs is not completely clear and the role of the crosstalk between SPP1+ macrophages and CAFs has not been verified in clinical trials, SPP1-blockading is promising for improving the efficacy of HCC treatment with ICIs.